Diabetes

n-3 PUFA may reduce markers of kidney disease in T2DM

(HealthDay)—In patients with type 2 diabetes and evidence of kidney injury, supplementation with n-3 long-chain polyunsaturated fatty acids (PUFA) does not reduce urine albumin excretion but is associated with a reduction ...

Alzheimer's disease & dementia

Developing novel biomarkers to predict Alzheimer's disease

Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months ...

Diseases, Conditions, Syndromes

Biosignatures distinguish between tuberculosis and sarcoidosis

With a range of diseases, doctors need unique features which they can use to unequivocally identify a patient's illness for an appropriate diagnosis. Scientists therefore search for the biomarkers for an illness or a combination ...

page 2 from 2